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Ouabain Enhances ADPKD Cell
Apoptosis via the Intrinsic Pathway
Jessica Venugopal and Gustavo Blanco*
Department of Molecular and Integrative Physiology and The Kidney Institute, University of Kansas Medical Center, Kansas
City, KS, USA
Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly
influenced by factors circulating in blood. We have shown that the hormone ouabain
enhances several characteristics of the ADPKD cystic phenotype, including the rate
of cell proliferation, fluid secretion and the capacity of the cells to form cysts. In this
work, we found that physiological levels of ouabain (3 nM) also promote programmed
cell death of renal epithelial cells obtained from kidney cysts of patients with ADPKD
(ADPKD cells). This was determined by Alexa Fluor 488 labeled-Annexin-V staining
and TUNEL assay, both biochemical markers of apoptosis. Ouabain-induced apoptosis
also takes place when ADPKD cell growth is blocked; suggesting that the effect is not
secondary to the stimulatory actions of ouabain on cell proliferation. Ouabain alters the
expression of BCL family of proteins, reducing BCL-2 and increasing BAX expression
levels, anti- and pro-apoptotic mediators respectively. In addition, ouabain caused the
release of cytochrome c from mitochondria. Moreover, ouabain activates caspase-3, a
key “executioner” caspase in the cell apoptotic pathway, but did not affect caspase-8.
This suggests that ouabain triggers ADPKD cell apoptosis by stimulating the intrinsic, but
not the extrinsic pathway of programmed cell death. The apoptotic effects of ouabain
are specific for ADPKD cells and do not occur in normal human kidney cells (NHK
cells). Taken together with our previous observations, these results show that ouabain
causes an imbalance in cell growth/death, to favor growth of the cystic cells. This event,
characteristic of ADPKD, further suggests the importance of ouabain as a circulating
factor that promotes ADPKD progression.
Keywords: Na, K-ATPase signaling, polycystic kidney disease, programmed cell death, BCL-2 proteins,
cytochrome c, caspase
INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disorder
of the kidney, characterized by the formation and progressive enlargement of numerous fluid filled
cysts, which severely distort renal morphology and function, reviewed inGrantham (2008) and Paul
and Vanden Heuvel (2014). ADPKD cysts are formed in utero and continue progressing after birth
at a relatively slow, but relentless rate throughout the life of the affected individual (Grantham et al.,
2010). Patients with ADPKD eventually develop renal insufficiency and end-stage renal disease
(ESRD), requiring dialysis or kidney replacement therapy (Alam and Perrone, 2010; Grantham
et al., 2011; Kanaan et al., 2014).
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ADPKD is caused by mutations in the genes that encode
for polycystin-1 and polycystin-2 (Pkd1 and Pkd2 respectively);
however, progression of the disease is highly influenced by factors
circulating in the bloodstream (Pei, 2011; Fedeles et al., 2014; Ong
and Harris, 2015). We have shown that the hormone ouabain, in
concentrations similar to those present in plasma, stimulate the
proliferation of renal epithelial cells obtained from kidney cysts of
patients with ADPKD (ADPKD cells), the growth of microcysts
generated by ADPKD cells, and cyst-like tubule dilations in
embryonic kidneys from a mouse model of ADPKD (Nguyen
et al., 2007; Jansson et al., 2012). In contrast, ouabain does not
significantly influence cell proliferation and cyst formation in
normal kidney cells (NHK cells) and metanephric organs from
wild type mice (Blanco and Wallace, 2013).
The slow progression of ADPKD is difficult to explain in
a condition that is primarily characterized by continuous cell
proliferation. Cell growth is maintained by a balance between
cell proliferation and apoptosis, a process of programmed cell
death (Green and Llambi, 2015; Savitskaya and Onishchenko,
2015). Interestingly, an imbalance between increased rates of cell
apoptosis have been reported in kidneys from animal models of
ADPKD and in humans carrying the disease, a phenomenon that
may contribute to the uncontrolled, but slow progression of the
disease (Lanoix et al., 1996; Zhou and Kukes, 1998; Murcia et al.,
1999; Torres, 1999; Edelstein, 2005; Ibrahim, 2007; Goilav et al.,
2008; Ibraghimov-Beskrovnaya and Bukanov, 2008).
Apoptosis is an essential process during normal tissue
development and aging and is also found in several pathological
situations (Elmore, 2007; Tezil and Basaga, 2014; Arya and
White, 2015; Labi and Erlacher, 2015). Apoptosis involves an
intricate cascade of molecular events, with the B-cell lymphoma
2 (BCL-2) protein family and a series of cysteine proteases, the
caspases, being essential mediators of the process. The BCL-
2 family include several members that are pro-survival and
pro-apoptotic factors, such as BCL-2 and BAX respectively.
The proteolytic caspases include the “initiator” caspases-8, -9,
and -10, and the “executioner” caspases 3 and 7 (Elmore,
2007; Green and Llambi, 2015; Zheng et al., 2015). Two main
caspase-mediated pathways control programmed cell death.
The extrinsic pathway, a ligand triggered and transmembrane
receptor mediated cascade (Ashkenazi, 2015), and the intrinsic
pathway, which comprises mitochondrial changes and the release
of cytochrome c from the mitochondrial intermembrane space
to the cell cytosol (Brenner and Mak, 2009). Both intrinsic
and extrinsic pathways converge to stimulate the activity of
caspases-3 and -7, which are responsible for the events that
are characteristic of apoptosis, including DNA fragmentation,
protein cross-linking and degradation, and cell disintegration
into apoptotic bodies (Salvesen and Riedl, 2008).
While apoptosis has been described as a feature of ADPKD,
the factors and mechanisms that influence programmed cell
death in ADPKD cells are poorly understood. Ouabain has
been shown to influence programmed cell death in a cell
type specific manner. For instance, ouabain has pro-apoptotic
effects in normal neuronal cells, neuro- and glioblastoma cells,
hepatic cells, blood peripheral lymphocytes, lymphoma cells, and
prostate cancer cells (Olej et al., 1998; Xiao et al., 2002; Huang
et al., 2004; Esteves et al., 2005; Kulikov et al., 2007; Panayiotidis
et al., 2010; Xu et al., 2010; Fu et al., 2013; Yan et al., 2015).
In contrast, ouabain protects endothelial cells, cerebellar granule
cells, renal proximal tubule, and COS-7 cells against apoptosis
(Isaev et al., 2000; Orlov et al., 2004; Trevisi et al., 2004, 2006; Li
et al., 2010; Dvela et al., 2012; Burlaka et al., 2013); and has a dual
pro- and anti-apoptotic effect in smooth muscle, umbilical vein
endothelial cells, and fibroblast (Chueh et al., 2001; Winnicka
et al., 2010; Ren et al., 2014). At present, the role of ouabain
in ADPKD apoptosis is unknown. In this work, we show that
ouabain enhances apoptosis in ADPKD, but not in NHK cells,
by activating the intrinsic pathways of programmed cell death.
MATERIALS AND METHODS
Cell Culture
Primary cell cultures of ADPKD cells, derived from surface
cysts of ADPKD kidneys and NHK cells were generated by the
PKD Biomaterial Core at University of Kansas Medical Center
(KUMC). A protocol for the use of discarded human kidney
tissues was approved by the Institutional Review Board at KUMC.
Primary cultures were prepared as described (Wallace et al.,
1996). Cells were seeded and grown inDMEM/F12 supplemented
with 5% heat-inactivated fetal bovine serum (FBS), 100 IU/ml
penicillin G and 0.1mg/ml streptomycin, 5µg/mL insulin,
5µg/mL transferrin, and 5 ng/mL sodium selenite (ITS). Twenty-
four hours before, cells were subjected to various experimental
manipulations, serum was reduced to 0.002% and ITS removed.
As previously shown, these cells are epithelial in nature and they
stain positive for specific lectin markers for the collecting duct
and distal nephron, indicating that they are derived from the
distal nephron (Yamaguchi et al., 2003).
Annexin-V and Propidium Iodide Staining
Alexa Fluor 488 labeled-Annexin-V and propidium iodide (PI)
staining were utilized as biomarkers for the detection of apoptosis
and necrosis in ADPKD and NHK cells by flow cytometric
analysis, following the manufacturer’s protocols (Invitrogen,
Carlsbad, CA, USA). Briefly, cells were trypsinized, washed
in PBS, and resuspended in binding buffer (50mM HEPES,
700mM NaCl, 12.5mM CaCl2, pH 7.4). After addition of
5µL Annexin-V and 1µL PI, cells were incubated at 37◦C
and protected from light for 15min. Samples were diluted
with binding buffer and were analyzed using a LSRII flow
cytometer (Beckton Dickinson, Franklin Lakes, NJ). Alexa Fluor
488 labeled-Annexin-V, which detects changes in distribution
of phosphatidylserine and phosphatidylethanolamine at the
cell plasma membrane; and propidium iodide (PI) staining,
which reveals loss of cell plasma membrane integrity, allowed
distinguishing cells undergoing early and late stages of apoptosis,
and necrosis (Ravichandran, 2010).
Measurement of Fragmented DNA by
TUNEL Assay
Cells cultured on glass coverslips were treated with 3 nM
ouabain for 24 h and analyzed for apoptosis using the DeadEnd
fluorometric TUNEL system (Promega, Madison, WI). This
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method determines nuclear fragmentation, an important
biochemical marker for cell apoptosis, by using terminal
deoxynucleotidyl transferase to transfer fluorescein (FITC)-
12-dUTP to the free 3′-OH of cleaved DNA. Cells were
counter-stained with DAPI to label the nuclei. The percentage of
cells undergoing apoptosis was determined using fluorescence
microscopy. Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-
fluoro-methylketone (z-VAD-fmk), at a concentration of 20µM
and camptothecin, at 5µM (Promega Corporation, Madison,
WI), were applied as an inhibitor and inducer of apoptosis,
respectively.
Immunoblot Analysis
Cells treated with and without 3 nM ouabain for 24 h were
washed once with ice-cold phosphate buffered saline (PBS) and
lysed in a solution containing 10mM Tris-Cl (pH 7.4), 10mM
NaCl, 3mM MgCl2, and 0.1% NP-40. Samples were centrifuged
at 10,000 × g for 10min. Protein amounts were determined
by Bio-Rad Protein Assay (Bio-Rad, Hercules, CA). Fifty µg
of the cleared lysates were subjected to SDS-PAGE (15% gel)
and blotted on to nitrocellulose membranes. Immunoblots were
probed with different primary antibodies that recognize PARP-1,
BCL-2, BAX, caspase-3 or caspase-8 (Cell Signaling Technology,
Boston, MA). Species-specific secondary antibodies conjugated
to horse-radish peroxidase and enhanced chemiluminescence
was used for protein detection (Santa Cruz Biotechnology, Dallas,
TX). Protein expression levels were determined by densitometry
and were expressed as a ratio of the corresponding untreated
controls.
Cytochrome C Analysis
Cytochrome c release from mitochondria was studied in
NHK and ADPKD cells after treatment with or without 3 nM
ouabain for 24 h by immunoblot and immunocytochemistry.
For the immunoblot analysis, cells were harvested and cytosolic
or mitochondrial fractions were prepared using the Cell
Fractionation Kit ab109719, according to the manufacturer’s
instructions (AbCam, Cambridge, UK). Samples were subjected
to SDS/PAGE and proteins transferred to nitrocellulose
membranes. Cytochrome c was determined using a monoclonal
antibody from BD Biosciences (San Diego, CA) and horse-radish
peroxidase conjugated secondary antibodies; and its levels
were estimated by densitometric analysis of the bands obtained
from the cytoplasmic fractions. For the immunocytochemical
analysis, cells were plated on coverslips and treated with or
without ouabain for 23.5 h. Then, 100 nM MitoTracker Red
CMXRos (Thermo Fisher Scientific, Waltham, MA) was added
to the cells and they were incubated for an additional 30min
at 37◦C, protected from light. Cells were fixed with 3.7%
paraformaldehyde in serum-free media for 15min at 37◦C.
Samples were washed in PBS and permeabilized with acetone for
5min. Anti-cytochrome c antibody (BD Biosciences, San Diego,
CA) (1:75) was applied to the cells overnight at 4◦C. Coverslips
were washed once with PBS, and then slides were incubated
with secondary Alexa 488-conjugated antibodies for 1 h at
room temperature. Samples were washed in PBS and mounted
onto microscope slides with DAPI Slowfade Gold solution
(Thermo Fisher Scientific, Grand Island, NY). Slides were viewed
using a Eclipse 80i Upright microscope (Nikon Instruments,
Inc., Melville, NY). Analysis of cytochrome c release from the
mitochondria was quantified as the ratio of cytochrome c release
was determined from the obtained images, by quantifying the
number of pixels in the cell cytosol divided by the number
of pixels in mitochondria. Values were expressed as the ratio
of cytosolic/mitochondrial cytochrome c levels, as previously
described (Gao et al., 2001). This allowed characterizing the
mitochondrial to cytosolic distribution of cytochrome c.
Caspase-3/7 Activity Determination
Caspase-3/7 activity was determined using the Caspase-Glo
3/7 Assay according to manufacturer’s instructions (Promega,
Madison, WI). Briefly, NHK and ADPKD cells were plated
into black-walled, clear-bottomed 96-well plates (Corning Inc.,
Corning, NY) at a density of 4000 cells per well and treated
with or without ouabain for 24 h. The luminescent caspase-3/7
substrate was added following the manufacturers specifications.
The luminescent signal resulting from cleavage of the substrate
specific to caspase-3 or -7 is proportional to the amount of
caspase activity present. Data were expressed as a percentage of
untreated controls.
Data Analysis
Statistical significance of the differences between ouabain treated
and untreated controls was determined by Student’s T-test.
Also, Bonferroni’s test was applied as another way to confirm
statistically significant differences. Statistical significance was
defined as P < 0.05.
RESULTS
Ouabain Stimulates Apoptosis in ADPKD
but Not in NHK Cells
Ouabain has been reported to stimulate apoptosis in a cell
type specific manner (Silva and Soares-da-Silva, 2012). We
explored weather ouabain affected programmed cell death in
NHK and ADPKD cells. For this, we treated NHK and ADPKD
cells with 3 nM ouabain, a concentration of this hormone
that is within the levels commonly found to be circulating in
blood. Twenty-four hours later, we determined cell apoptosis
and necrosis using Alexa Fluor 488 labeled-Annexin-V and PI
labeling and flow cytometry. Sorting of the cells based on these
markers showed that ouabain treatment caused a modest but
significant increase in the number of ADPKD cells undergoing
apoptosis compared to untreated controls (Figure 1A, top panel).
This increase corresponded to cells showing signs of late
apoptosis, while the number of ADPKD cells showing early
manifestations of apoptosis, or undergoing necrosis did not
significantly change with ouabain administration (Figure 1A,
bottom panel). Different from ADPKD cells, ouabain did not
induce programmed cell death (either early or late apoptosis), or
necrosis in NHK cells (Figure 1A, top and bottom panels).
To further estimate apoptosis, we determined DNA nuclear
fragmentation by TUNEL assay in NHK and ADPKD cells.
In agreement with the Alexa Fluor 488 labeled-Annexin-V
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FIGURE 1 | Ouabain induces apoptosis in ADPKD, but not in NHK cells.
(A) Alexa Fluor 488 labeled-Annexin V and PI staining. After treatment with
ouabain for 24 h, cells were labeled and sorted using flow cytometry. The top
panel shows representative plots for the sorted NHK and ADPKD cells,
without and with of ouabain. Different cell populations undergoing necrosis,
early and late apoptosis, identified by differential annexin-V/PI labeling, were
quantified and expressed as percent of total cells (bottom panel). (B) DNA
fragmentation assays. Cells seeded onto glass coverslips were incubated with
3 nM ouabain and the indicated experimental conditions for 24 h, fixed and
analyzed for apoptosis using the Dead-End Fluormetric TUNEL System.
Fragmented DNA was labeled by incorporation of fluorescein-12-dUTP(a) at
3′-OH DNA ends. The nuclei were counterstained with DAPI and visualized by
immunofluorescence microscopy. At least 10 random fields were analyzed
from each of three different ADPKD kidneys. In all graphs, bars represent the
mean ± SEM of three different experiments. The asterisks indicate values that
are statistically different compared to the corresponding untreated control, with
P < 0.05.
and PI studies, ouabain slightly, but statistically significantly
increased TUNEL staining in ADPKD cells (Figure 1B). This
ouabain-induced increase in DNA fragmentation could be
rescued by the pan-caspase inhibitor, carbobenzoxy-valyl-alanyl-
aspartyl-[O-methyl]-fluoro-methylketone (z-VAD-fmk), further
suggesting that ouabain is inducing apoptosis in ADPKD cells.
The topoisomerase I inhibitor, camptothecin, was used as a
positive control for apoptosis (Figure 1B). Altogether, these
experiments show that ouabain stimulates apoptosis in ADPKD,
but not in NHK cells.
Ouabain Modulates Expression of BCL-2
Protein Family Members in ADPKD Cells
Whether a cell undergoes apoptosis is in part determined by the
ratio of pro- to anti-apoptotic members of the BCL-2 protein
family (Green and Llambi, 2015). Within the BCL-2 members,
BAX and BAK function as pro-apoptotic agents, while BCL-2
behaves as an anti-apoptotic mediator (Zheng et al., 2015). To
further characterize the mechanisms by which ouabain induces
cell death in renal normal and cystic cells, we examined the role
of these apoptotic regulators in NHK and ADPKD cells. Ouabain
treatment for 24 h did not alter the expression levels of either
BAX or BCL-2 proteins in NHK cells (Figure 2A). However, in
ADPKD cells, ouabain caused a significant decrease in the anti-
apoptotic BCL-2 protein, with a concomitant increase in the pro-
apoptotic BAX protein levels (Figure 2B). This change toward a
pro-apoptotic protein ratio supports the role of ouabain as an
inducer of apoptosis in ADPKD cells, and suggests that its effects
are mediated via the intrinsic pathway of programmed cell death.
Ouabain Enhances Cytochrome C Release
from ADPKD Cell Mitochondria
A pro-apoptotic change in BCL-2/BAX protein ratio is
commonly followed by the release of cytochrome c from
mitochondria, another event in the activation cascade of
programmed cell death (Li and Dewson, 2015; Um, 2015).
Therefore, we determined the release of cytochrome c from
mitochondria, by measuring the levels of cytochrome c
in cytoplasmic fractions from NHK and ADPKD cells by
immunoblot. As expected, and as shown in Figure 3A,
cytochrome c levels were much higher in the mitochondrial
than in the cytosolic fractions of both NHK and ADPKD
cells. Importantly, cytochrome c was significantly augmented
by ouabain in cytosolic fractions from ADPKD, but it was
slightly decreased in NHK cells (Figure 3A). Due to the disparity
between the high saturating levels of cytochrome c, typical of
mitochondria, and the normal low levels of cytochrome c found
in cytoplasm, we used higher exposure times for the development
of the immunoblots corresponding to the cytosolic than the
mitochondrial cell fractions from the same blot. This allowed us
to perform a better quantification of the cytochrome c bands in
the cell cytosol; which, along with the sole presence of VDAC in
mitochondria, support the lack of any major cross contamination
between mitochondrial and cytoplasmic samples. The increase in
cytochrome c in the cytoplasm suggests that the change in BCL-
2/BAX ratio in ADPKD cells did result in release of cytochrome
c from the cell mitochondria.
In addition, changes in cytochrome c localization were
studied by immunocytochemistry. For this, cells were labeled
with MitoTracker Red, a dye which allows the visualization
of mitochondria, and an anti-cytochrome c. Then, the ratio
of cytoplasmic to mitochondrial localization of cytochrome c
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FIGURE 2 | Ouabain modifies the expression of BCL-2 and BAX protein levels in ADPKD, but not NHK cells. NHK (A) and ADPKD (B) cells were treated in
the absence and presence of 3 nM ouabain and 24 h later, expression levels of BCL-2 and BAX were determined by immunoblot. Tubulin was used as a loading
control. Top panels show the densitometric analysis of the protein bands, while bottom panels show representative blots. Bars are the mean ± SEM of three
experiments. Asterisks indicate statistically different values, with P < 0.05 vs. untreated control.
was determined by quantification of pixel density as described
(Gao et al., 2001). As shown in Figure 3B, the ratio of
cytoplasmic/mitochondrial cytochrome c did not change with
ouabain treatment in NHK cells. In contrast, this ratio was
significantly increased by ouabain in ADPKD cells (Figure 3B).
Altogether, these results show that ouabain promotes the release
of cytochrome c from the mitochondria of ADPKD cells and
agree with the notion that ouabain induces apoptosis in these
cells.
Ouabain Activates Caspase-3/7 in ADPKD
Cells
Proteases of the caspase family play an essential role in
the cleavage of specific substrates that mediate cell apoptosis
(Zhivotovsky, 2003; Poreba et al., 2013). To assess the
involvement of caspases in ouabain-induced apoptosis of
ADPKD cells, we treated NHK and ADPKD cells in the
presence and absence of 3 nM ouabain for 24 h and determined
activation of the “executioner” caspase-3 via its cleavage status.
Caspase-3 cleavage was determined by immunoblot. As shown
in Figure 4A, caspase-3 cleavage was not modified by ouabain
in NHK cells (left panels). In contrast, in ADPKD cells, ouabain
significantly increased the cleavage of pro-caspase-3 into its
active large (p17) and small (p12) fragments (right panels).
In addition, we directly measured the levels of caspase-3
activity, in ADPKD cells treated with and without 3 nM ouabain.
Once activated, caspase-3 cleaves the same peptide sequences
than caspase-7 and their activities cannot be distinguished with
the assay that we used. In any case, both caspase-3 and -7
are “executioner” caspases, involved in downstream cleavage of
substrates that mediate many of the typical biochemical and
morphological events of apoptosis (Zhivotovsky, 2003; Poreba
et al., 2013). As shown in Figure 4B, ouabain significantly
stimulated caspase-3/7 activity of ADPKD cells.
Ouabain dependent caspase-3 activation by ouabain was
also estimated by immunoblot analysis of poly (ADP-ribose)
polymerase-1 (PARP-1), a known target of caspase-3 action
(Kauppinen and Swanson, 2007). Consistent with activation of
caspase-3, ouabain increased the cleavage of PARP-1 in ADPKD
cells, but not in NHK cells (Figure 4C).
Ouabain Does Not Activate the Extrinsic
Pathway of ADPKD Cell Apoptosis
The factors involved in triggering cell apoptosis can act through
two main mechanisms, the intrinsic and extrinsic pathways
(Green and Llambi, 2015). Our findings that ouabain stimulates
the release of cytochrome c from mitochondria suggest a
role for the intrinsic pathway in the mechanisms leading to
ouabain-mediated apoptosis in ADPKD cells. To determine
the involvement of the extrinsic pathway in ouabain-induced
ADPKD apoptosis, we measured the activation of caspase-8. This
protease is involved in the extrinsic pathway of programmed cell
death and its cleavage is a marker for its activation (Salvesen,
1999). We treated NHK and ADPKD cells in the presence and
absence of 3 nM ouabain for 24 h and determined the total
and cleaved forms of caspase-8 by immunoblot. Compared to
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FIGURE 3 | Ouabain stimulates cytochrome C release from mitochondria in ADPKD, but not NHK cells. (A) Immunoblot analysis. After treatment with or
without 3 nM ouabain for 24 h, cells were processed to obtain cell cytoplasmic and mitochondrial fractions, and samples were subjected to immunoblot analysis to
determine cytochrome c levels. Tubulin was used as a loading control, while VDAC was used as a mitochondrial marker. The bottom panels show representative
immunoblots. Relative densitometric levels for cytochrome c in the cytoplasm are shown in the upper panels and they represent data compiled from four different
experiments. Due to the difference between mitochondrial and cytoplasmic cytochrome c levels, and to better quantify the cytoplasmic bands, different exposure
times for the cytochrome c cytosolic and mitochondrial samples from the same immunoblots were used. (B) Immunocytochemical analysis. After treatment with 3 nM
ouabain for 24 h, NHK and ADPKD cells were labeled for cytochrome c and MitoTracker, to visualize mitochondria. Cytochrome c release was quantified and
expressed as the cytosol to mitochondrial ratio. Bars represent the compiled data from 3 different experiments. In A and B, bars represent the mean ± SEM. Asterisks
indicate statistically different values, with P < 0.05 vs. untreated control.
untreated controls, ouabain unexpectedly, decreased caspase-8
cleavage in NHK cells (Figure 5A), but it did not affect caspase-8
cleavage in ADPKD cells (Figure 5B). These results suggest that
the apoptotic effects of ouabain in ADPKD cells are not mediated
by caspase-8 and the extrinsic pathway of programmed cell death.
In addition, the reduction in caspase-8 in NHK cells suggests a
protective effect of ouabain toward apoptosis in normal cells.
The Effect of Ouabain on ADPKD
Apoptosis is Independent from Cell
Proliferation
We have previously shown that ouabain enhances the growth
of ADPKD cells (Nguyen et al., 2007). The ouabain-induced
activation of apoptosis that we observe in ADPKD cells
could just be secondary to the high proliferative effects that
ouabain has in these cells. To investigate this possibility,
we inhibited cell proliferation in NHK and ADPKD cells
with thymidine, and treated the cells with 3 nM ouabain
for 24 h. Finally, we determined apoptosis levels by cell
sorting, after labeling the cells with Alexa Fluor 488 labeled-
Annexin-V. As shown in Figure 6A, ouabain had no effect
on NHK cell early or late apoptosis, either in the presence
of absence of thymidine. In ADPKD cells, ouabain activated
programmed cell death, even when cell proliferation was
blocked with thymidine (Figure 6B). This shows that the
effects of ouabain on ADPKD cell apoptosis directly target
programmed cell death and they are not an indirect consequence
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FIGURE 4 | Ouabain stimulates caspase-3 cleavage and activity in ADPKD, but not NHK cells. (A) Caspase-3 cleavage. After treatment with 3 nM ouabain
for 24 h, the total (35 kDa) and cleaved products (17 and 12 kDa) of caspase-3 were determined in NHK and ADPKD cells by immunoblot and densitometric analysis.
Upper panels show representative blots and bottom panels the densitometric analysis from three different experiments. Bars are the mean ± SEM of three
experiments. (B) Relative caspase-3 and -7 activity levels. ADPKD cells were treated in the absence and presence of 3 nM ouabain and caspase activity was
measured using the Caspase-3/7 Glo Assay. Data are the mean ± SEM of sextuplicate experiments. (C) PARP-1 cleavage. After ouabain treatment for 24 h, NHK and
ADPKD cell lysates were subjected to immunoblot to determine fragmentation of the caspase-3 substrate, PARP-1. The top panels show the densitometric analysis of
the total and cleaved (89 kDa) PARP-1 bands. Cleaved PARP-1 is expressed relative to the corresponding untreated controls. The bottom panels show representative
immunoblots. Bars represent the mean ± SEM of 5 different experiments. Asterisks show statistically different values, compared to untreated controls and with
P < 0.05.
of the exacerbated growth that the hormone causes in the
cells.
DISCUSSION
In this work we have shown that ouabain stimulates apoptosis
in human ADPKD cells. Thus, ouabain causes changes in
plasma membrane phospholipids, induces DNA fragmentation,
alters the balance of BCL-2 protein expression, favors release
of cytochrome c from mitochondria, and activates caspase-3/7;
all of which are typical events of programmed cell death. We
found that the levels of apoptosis that ouabain promotes are
modest; however, this agrees with the apoptosis seen in ADPKD
cells, which cannot compensate for the proliferative nature of
the disease (Woo, 1995; Lanoix et al., 1996). Also, we found
that apoptosis levels varied depending on the method used
for cell death determination, being slightly higher when Alexa
Fluor 488 labeled-Annexin-V/PI was used, as compared to tunel
assay. This may reflect differences in the end points measured
in each case (plama membrane vs. DNA changes respectively),
or differences in the sensitivity of each assay. Ouabain-induced
ADPKD apoptosis occurs even when cell proliferation in the
cells is blocked. This suggests that the enhancement of ADPKD
cell apoptosis by ouabain is due to a direct action of ouabain
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FIGURE 5 | Ouabain does not affect the extrinsic pathway for apoptosis in ADPKD cells. NHK (A) and ADPKD (B) cells were treated with 3 nM ouabain for
24 h and the total (41/43 kDa) and cleaved (37 kDa) forms of caspase-8 were determined by immunoblot analysis and quantified by densitometry. The top panels
show the densitometric analysis of the bands from 4 different experiments. The bottom panels show representative blots. Values are the mean ± SEM. Asterisks
indicate statistically different values, with P < 0.05 vs. untreated control.
FIGURE 6 | Ouabain induces ADPKD cell apoptosis independent from its proliferative effects. NHK (A) and ADPKD (B) cells were treated with or without
3 nM ouabain, in the presence and absence of 2.5M thymidine to arrest cell growth. Alexa fluor-labeled-annexin-V and PI staining and cell sorting were utilized to
detect apoptosis/necrosis. Bars represent the mean ± SEM of 3 different experiments. While the values for ouabain induced apoptosis were statistically significant
between NHK and ADPKD cells (P < 0.05), no statistical differences were found between cells treated with ouabain in the presence and absence of thymidine, both
for NHK or ADPKD samples.
on programmed cell death, and not a secondary consequence of
increased cell growth, which is another effect induced by ouabain
in these cells (Blanco and Wallace, 2013). The role of ouabain on
apoptosis has been shown to be cell type dependent (Silva and
Soares-da-Silva, 2012). Similar to ADPKD cells, various cancer
cell types either undergo apoptosis when treated with ouabain,
or are sensitized for apoptosis triggered by other compounds
(Huang et al., 2004; Winnicka et al., 2007; Qiu et al., 2008; Bloise
et al., 2009; Xu et al., 2010; Platonova et al., 2011; Alonso et al.,
2013; Chen et al., 2014;Wang et al., 2014). Therefore, ADPKD are
not the only diseased cells that react to ouabain with an apoptotic
response.
We show that, different from ADPKD cells, ouabain does
not induce apoptosis in NHK cells. In agreement with these
observations, ouabain does not trigger programmed cell death
in renal proximal tubule cells and explanted embryonic kidneys
from normal rats. Moreover, in those studies, ouabain was shown
to have a protective effect against apoptosis induced by serum-
starvation (Li et al., 2010) and Shiga toxin-2 infection (Burlaka
et al., 2013). While the goal of our experiments was not to explore
the effects of ouabain under stimuli that challenge the cells to
undergo apoptosis, we find a decrease in cytochrome c release
from mitochondria, a reduction of ouabain-induced caspase-
8 cleavage, and a trend for lower caspase-3 cleavage in NHK
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cells after ouabain treatment. This suggests that ouabain may be
shifting NHK cells toward a pro-survival phenotype. In any case,
it appears that, despite the differences in species and renal origin,
ouabain acts as a pro-survival agent in normal kidney cells.
Interestingly, increased apoptosis is a feature of early and
late stages of human ADPKD (Woo, 1995; Lanoix et al., 1996),
and it is linked to cystogenesis in various animal models of
polycystic kidney disease (Moser et al., 1997; Trudel et al.,
1998; Lin et al., 1999; Lager et al., 2001). ADPKD apoptosis
has been shown to take place in the epithelial cells lining
the kidney cysts, and in cysts formed by Madin-Darby canine
kidney cells (MDCK) grown in collagen matrix, a model of
kidney cystic disease (Woo, 1995; Lin et al., 1999; Ecder et al.,
2002; Ibrahim, 2007). Moreover, polycystin 1, the primary
gene altered in ADPKD, has been shown to be a regulator of
programmed cell death in renal cells, and its over-expression
confers the host cells resistance to apoptosis (Boletta et al.,
2000). Apoptosis has also been detected in non-cystic tissue
in ADPKD kidneys, which suggests that programmed cell
death of the normal remaining kidney contributes to the
progressive deterioration of ADPKD renal function (Woo, 1995;
Ibrahim, 2007; Goilav et al., 2008). Therefore, it appears that
apoptosis is an essential concomitant event that helps kidney
cyst development, and along with cell proliferation contributes
to the pathophysiology of ADPKD. Our results show that in
human cells, the target for ouabain-induced apoptosis is the
cystic, ADPKD cells, and not the NHK cells. The apoptotic
effect of ouabain in ADPKD cells, along with the aberrant
increase that ouabain promotes in ADPKD cell growth (Nguyen
et al., 2007), places ouabain as a modulator of two essential
mechanisms involved in the pathophysiology of ADPKD. It is
clear that that the increase in apoptosis caused by ouabain is
not sufficient to overcome the ouabain-induced ADPKD cell
growth. Therefore, ouabain functions as a factor that creates
a dysregulation of ADPKD cell growth/death, in favor of cell
proliferation.
Our studies used amounts of ouabain that are within those
circulating in plasma (Bagrov et al., 2009). This highlights
the relevance of ouabain as a factor that contributes to the
pathophysiology of ADPKD. At present, the molecular basis for
the different responses of ADPKD and NHK cell to ouabain is
unclear; however, we have previously found that, different from
NHK cells, ADPKD cells contain a fraction of the total Na,K-
ATPase with an abnormal higher affinity for ouabain (Nguyen
et al., 2007). Due to their increased ouabain affinity, ADPKD
cells may be just more susceptible to the endogenous circulating
levels of ouabain, to which NHK cells do respond to the same
extent. In addition to their differential sensitivity to ouabain,
ADPKD cells also differ from NHK cells in the activity of several
intracellular signaling pathways. For example, it is known that the
kinase B-Raf and the ERK pathway have an abnormal reactivity
to different circulating factors in ADPKD cells (Yamaguchi et al.,
2003; Rajagopal and Wallace, 2015). It is therefore possible
that, in ADPKD cells, ouabain impinges on pathways which
respond in an exacerbatedmanner on apoptotic effectors to cause
programmed cell death. Undoubtedly, more studies are necessary
before we can fully understand the molecular mechanisms by
which ADPKD cells respond differently to the variety of stimuli
that circulate in blood, including ouabain.
As shown from our labeling experiments with PI, ouabain
does not cause cell necrosis, which suggests that ouabain effects
are non-toxic for the ADPKD cells. This agrees with the notion
that, in ADPKD cells, ouabain is not completely inhibiting Na,K-
ATPase ion transport, but that at relatively low, physiologic
amounts, it activates downstream effectors, as we have shown
before (Nguyen et al., 2011). In further support of this, we here
found that ouabain activates several mediators in the signaling
pathway that leads to apoptosis. Thus, in ADPKD, but not NHK
cells, ouabain causes an inbalance in the expression of the BCL-
2 and BAX proteins, involved in anti- and pro-apoptotic effects
respectively. Ouabain slightly inhibited BCL-2 expression and
augmented BAX levels, agreeing with induction of apoptosis
in the cells. Interestingly, BCL-2 deficient mice show increased
kidney apoptosis and the development of renal cyst disease (Veis
et al., 1993). The downregulation of BCL-2 and the pro-apoptotic
effects of ouabain may represent mechanisms, which together
with those on cell growth and fluid secretion, contribute to
the enhancement of the cystic phenotype of ADPKD cells. The
decrease in BCL-2 protein concentration in response to ouabain
is not unique to ADPKD cells and it has been found in other
cell types (Kulikov et al., 2007; Sapia et al., 2010; Trenti et al.,
2014). Moreover, overexpression of either BCL-2 or BCL-XL has
been reported to abrogate the pro-apoptotic effects of ouabain
in a lymphoma cell line (Gilbert and Knox, 1997). Interestingly,
the involvement of the BCL-2 family of proteins in ouabain-
mediated effects in cells is also supported by the finding that
the Na,K-ATPase α subunit contains BH1- and BH3-like motifs,
similar to those involved in the pairing of BCL-2 family proteins
among each other (Zha et al., 1996; Lauf et al., 2015), and
that the BCL-2 family member proteins, BCL-XL and BAK1
co-immunoprecipitate with Na,K-ATPase in A549 lung cancer
cells and in fetal human epithelial lens cells (Lauf et al., 2015).
While it is unknown whether Na,K-ATPase acts as a scaffolding
protein to mediate pro-apoptotic effects via its BH1- and BH3-
motifs in ADPKD cells, it is clear that BCL family proteins
are involved in ouabain-induced apoptotic effects in the renal
epithelial cystic cells.
Besides stimulating the expression of BCL-2 protein, ouabain
also impacts on other important mediator of apoptosis in
ADPKD cells, such as the mitochondria, through the release
of cytochrome c. Moreover, ouabain activates the executioner
caspases 3 and 7. Instead, ouabain does not activate the cleavage
of caspase-8, an essential effector of the extrinsic apoptotic
pathway. Therefore, ouabain induces ADPKD cell apoptosis via
specific activation of the intrinsic pathway of programmed cell
death. Ouabain has been shown to activate the intrinsic apoptotic
pathway in other cell types (Xiao et al., 2002; Kulikov et al.,
2007; Alonso et al., 2013). Importantly, our results concur with
studies in the Han:SPRD rat, a rodent model of ADPKD, in
which the increase in apoptosis is dependent on activation of
the intrinsic pathway of programmed cell death (Edelstein, 2005;
Tao et al., 2005). In this manner, ouabain enhances an apoptotic
route, which commonly participates in ADPKD programmed cell
death.
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In summary, we have further advanced our understanding
of the effects of ouabain in ADPKD cells and found that
physiological amounts of ouabain stimulate apoptosis in these
cells through activation of the intrinsic pathway of programmed
cell death. Activation of this characteristic event of ADPKD,
together with other enhancing actions of ouabain on the ADPKD
phenotype (Blanco and Wallace, 2013), further supports the
role of ouabain as a non-genetic factor that can modulate renal
cystogenesis and the progression of ADPKD.
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